Biolife Sciences (Biolife Sciences) Total Liabilities : $3.46 Mil (As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Total Liabilities?

Biolife Sciences's Total Liabilities for the quarter that ended in May. 2008 was $3.46 Mil.

Biolife Sciences's quarterly Total Liabilities declined from Nov. 2007 ($3.70 Mil) to Feb. 2008 ($3.38 Mil) but then increased from Feb. 2008 ($3.38 Mil) to May. 2008 ($3.46 Mil).

Biolife Sciences's annual Total Liabilities increased from Nov. 2005 ($1.52 Mil) to Nov. 2006 ($3.22 Mil) and increased from Nov. 2006 ($3.22 Mil) to Nov. 2007 ($3.70 Mil).

Biolife Sciences Total Liabilities Historical Data

The historical data trend for Biolife Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Total Liabilities Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

Total Liabilities

0.02

1.52

3.22

3.70

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Total Liabilities	Get a 7-Day Free Trial										3.39	3.29	3.70	3.38	3.46

Biolife Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Biolife Sciences's Total Liabilities for the fiscal year that ended in Nov. 2007 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.496	+	(0.206	+	-2.7755575615629E-17
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3.70

Total Liabilities	=	Total Assets (A: Nov. 2007 )	-	Total Equity (A: Nov. 2007 )
	=	3.762	-	0.06
	=	3.70

Biolife Sciences's Total Liabilities for the quarter that ended in May. 2008 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.038	+	(0.421	+	0.0010000000000002
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3.46

Total Liabilities	=	Total Assets (Q: May. 2008 )	-	Total Equity (Q: May. 2008 )
	=	3.041	-	-0.419
	=	3.46

Biolife Sciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020